impact. In this discussion, we will explore the inter-dependency and contribution drug formulation have on device development and patient experience. We will also explore considerations around primary container component
oncogenes lead to abnormal growth i.e., development of cancer. Platinum complexes represent one of the most successful families of clinically used metalbased anticancer drugs; other transition metal complexes such
drugs being approved each year, and the increased costs associated with developing new drugs. At the same time, unprecedented advances in genomics, proteomics, molecular biology, and informatics have provided tremendous…
study was intended to develop a copolymer based carrier system of drug Risedronate (RIS) for its effective bone delivery at the target site for the treatment of osteoporosis (porous bone
pain. Currently, there are no small-molecule antagonists for PAC1 receptor aimed at developing an oral drug. Recently, we have discovered a novel small-molecule antagonist of the PAC1 receptor
last few decades. These therapeutic designs focus on developing several features to illuminate inflammations, protect the drug, and enhance the targeted delivery. While the choice of materials affects the efficiency…
that would allow scientists to do research more effectively. As a result of the development of web-database technologies (CDD Vault®), a collaborative approach to research on antibiotics and infectious ... easy access…
solution which draws from the rich semantic web vocabularies of the BioAssay Ontology, Drug Target Ontology, Gene Ontology, and others. On their own, these ontologies are not friendly to experimental ... have explored a…
However, key informants of the regulatory authority didn’t support additional tests on local drugs. Regarding ethical requirements, while the IRB members believed that IRB approval sufficed to conduct ... access but…
Collaborative Drug Discovery (CDD) provides trailing innovation for today’s chemical and biological data needs, differentiated by ease-of-use and superior, secure collaborative data sharing workflows. Within ... data…
characteristics of an ideal oral formulation, advantages and limitations with peptide therapeutics and drug development needs will be presented during the first part of the talk. Then preformulation and formulation
therapeutics. In the past 20 years, there have been more than 100 attempts to develop new pharmacological agents, including a wide range of therapeutics targeting different components of the amyloid ... overview of the…
develop and validate a rapid and simple stability indicating RP-HPLC method for simultaneous determination of two antiviral agents - pibrentasvir and glecaprevir in bulk drug and tablet dosage forms
specific diseases or variable drug response, so the r-DNA technology can easily develop a new drug molecule which can change the gene expression or may modify the targeted gene ... important insights and discoveries…
Phenotypic screening may provide an alternative or complementary approach to traditional molecular target-based drug discovery. Profiling of cellular phenotypes enables quantification of physiologically relevant traits…
white box” approach clearly does not deliver all the expected success in term of drug developments, mostly due to the lack of pathophysiological relevance of the models. Now, the pharmaceutical ... implementing new…
critical for the identification of patients at risk as well as for the development of drugs to treat or prevent these toxicities. The purpose of this presentation is to review ... Genetic associations hold tremendous…
autoimmune process blocks synaptic receptors or damages inhibitory neurons, channel-modulating anti-epileptic drugs are ineffective in many cases, and only immunotherapy can control the seizure. Empirical immunotherapy…
surface will allow us to deep in the design of new drug release systems with the potential to develop the clinical efficiency of the therapeutic effect of drug molecules
soluble drug, enhancing the delivery of DNA, and as a carrier for the development of novel drug delivery systems. The present research emphasizes the development of a conjugate of Dendrimer
good opportunity which was developed by Alpha M.O.S. In the sense of generic companies, developing a fast dissolving tablets version of an existing immediate-release product means that ... Release (ODT-ER) dosage forms…
effects on healthy tissues. For that reason, it is of great relevance to develop targeted drugs that can increase the local drug concentration, minimize toxic effects on off-target tissues ... reduce the dose…
growing further. Business strategies are changing to meet the market demand where formulation development and drug delivery system plays an important role. All big pharmaceutical companies are changing
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.